Sources Used in Current Review
(2016 November Updated). Inflammatory Bowel Disease – IBD. ARUP Consult. Available online at https://arupconsult.com/content/inflammatory-bowel-disease/?tab=tab_item-2. Accessed on 1/22/17.
Wang, Y. (2015 October 15). Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis. Int J Clin Exp Pathol 2015;8(10):12319-12332. Available online at https://ijcep.com/files/ijcep0013661.pdf. Accessed on 1/22/17.
Archbald-Pannone, L. (2014 March 17). Quantitative Fecal Lactoferrin as a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients. J Geriatr Palliat Care. 2014; 2(1): 3. Available online at https://pubmedcentralcanada.ca/pmcc/articles/PMC4230709/. Accessed on 1/22/17.
Zhou, X. et. al. (2014 July 7). Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis. BMC Gastroenterology 201414:121. Available online at https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-14-121. Accessed on 1/22/17.
Reuters Staff (2015 June 04). Diagnostic Accuracy of Noninvasive IBD Biomarkers Unclear. Reuters Health Information. Available online at https://www.medscape.com/viewarticle/845852. Accessed on 1/22/17.
Sources Used in Previous Reviews
Caccaro, R. et. al. (2012). Clinical Utility of Calprotectin and Lactoferrin in Patients With Inflammatory Bowel Disease. Medscape Today News from Expert Rev Clin Immunol v8 (6):579-585 [On-line information]. Available online at https://www.medscape.com/viewarticle/771596. Accessed February 2013.
Sherwood, R. (2012). Faecal Markers of Gastrointestinal Inflammation. Medscape Today News from J Clin Pathol. v65 (11):981-985 [On-line information]. Available online at https://www.medscape.com/viewarticle/773411. Accessed February 2013.
Tebo, A. (2013 January). Inflammatory Bowel Disease – IBD. ARUP Consult [On-line information]. Available online at https://www.arupconsult.com/Topics/IBD.html?client_ID=LTD. Accessed February 2013.
(© 1995–2013). Lactoferrin Detection. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at https://www.mayomedicallaboratories.com/test-catalog/Overview/91560. Accessed February 2013.
Wilkins, T. et. al. (2011 December 15). Diagnosis and Management of Crohn’s Disease. Am Fam Physician. v84 (12):1365-1375. [On-line information]. Available online at https://www.aafp.org/afp/2011/1215/p1365.html. Accessed February 2013.
Manohara, J. et. al. (2009 January). Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition v48 (1): 48-54. [On-line information]. Available online at https://journals.lww.com/jpgn/Fulltext/2009/01000/Fecal_Calprotectin_and_Lactoferrin_as_Noninvasive.8.aspx. Accessed February 2013.
Pfefferkorn, M. et. al. (2010 October). Utility of Fecal Lactoferrin in Identifying Crohn Disease Activity in Children. Journal of Pediatric Gastroenterology & Nutrition v51 (4): 425-428 [On-line information]. Available online at https://journals.lww.com/jpgn/Fulltext/2010/10000/Utility_of_Fecal_Lactoferrin_in_Identifying_Crohn.7.aspx. Accessed February 2013.
Delgado, J. and Grenache, D. (Updated 2012 October). Malabsorption. ARUP Consult [On-line information]. Available online at https://www.arupconsult.com/Topics/Malabsorption.html#tabs=0. Accessed February 2013.
Lewis, J. (2011). The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease. Gastroenterology v140:1817–1826. [On-line information]. PDF available for download at https://ibdsupplements.org/IBD/pdf/special/4.pdf. Accessed February 2013.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby’s Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 606-607.
Dai, J., W-Z Liu, and Y-P Zhao, et al. 2007. Relationship between fecal lactoferrin and inflammatory bowel disease. Scan J GastroEnt. 42:1440-1444. Available online at https://informahealthcare.com/doi/abs/10.1080/00365520701427094. Accessed March 2013.